AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2020
Jul 28, 2020
29809_dirs_2020-07-28_1d2bd5d3-a983-4e92-9d79-8840463c052a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2020-07-24
Reporting Person: DeSantis Robert (Executive VP & GM IA&E)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-24 | Common Stock | S | 1033 | $666.6872 | Disposed | 3348 | Direct |
| 2020-07-24 | Common Stock | M | 382 | $230.9967 | Acquired | 3730 | Direct |
| 2020-07-24 | Common Stock | S | 382 | $665.5686 | Disposed | 3348 | Direct |
| 2020-07-24 | Common Stock | M | 383 | $178.3867 | Acquired | 3731 | Direct |
| 2020-07-24 | Common Stock | S | 383 | $665.5686 | Disposed | 3348 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-24 | Non-Qualified Stock Option (right to buy) | $178.3867 | M | 383 | Disposed | 2026-02-16 | Common Stock (383) | Direct |
| 2020-07-24 | Non-Qualified Stock Option (right to buy) | $ | M | 382 | Disposed | 2026-08-15 | Common Stock (382) | Direct |
Footnotes
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 31, 2021.
F2: The average selling price for the transaction was $666.687162. The shares sold at $663.33-$663.42 = 300 shares; $664.75 - $664.84 = 200 shares; $665.13 = 17 shares; $667.65 = 100 shares; $668 = 100 shares; $670.133 - $670.65 = 316 shares.
F3: The average selling price for the transaction was $665.568628. The shares sold at $663.08-$663.42 = 400 shares;$665.13 = 12 shares;$666.66 = 100 shares; $667.65 - $667.65 = 100 shares; 668.98 = 100 shares; $670.44 - $670.47 = 53 shares.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F5: The exercise price to the shares underlying this grant is $230.9967, equal to 100% of the closing FMV of the Company on the date of grant.